Sudden outbreaks of COVID-19 in China “demonstrate the lack of effectiveness of its vaccines,” raising global concern, especially in countries where Beijing’s vaccines have been accepted, Tibet Press reported. sales, according to the report. As of December 2020, Indonesia and Brazil first reported 97% efficacy and 78% efficacy in Chinese vaccines.
In 2021, Indonesia and Brazil reduced power to 65% and 50. 4%. Both countries expressed concern about the main side effects of the COVID vaccine. After the resurgence of COVID-19 cases and deaths, Thailand and Singapore halted Chinese vaccines and began those conducted through AstraZeneca and Pfizer, according to Tibet Press.
In 2021, China administered 2400 million doses to its citizens and about 1300 million doses of vaccines were distributed worldwide. In 2022, Sinopharm claimed to have distributed more than 3500 million doses worldwide.
Most Chinese vaccine imports were made through Indonesia, Brazil, Pakistan, Turkey, Iran, the Philippines, Morocco, Thailand, Argentina, Venezuela, Cambodia, Sri Lanka, Chile, Mexico and Bangladesh, according to the report.
According to the “Statistical Table of Adverse Reactions to COVID-19 Vaccines” (2022) published through the Laishui County Community Health Center in Baoding City, Hebei Province, other people injected with Chinese vaccines have experienced adverse reactions, adding fever, nausea, diarrhea and other deaths, according to the Tibet Press report.
A document released by Baoding’s municipal leadership team for the outbreak reaction that was leaked online claimed that the Chinese government had quarantined a user for 47 days despite being fully vaccinated with Chinese-made vaccines.
The leaked documents were classified as “very pressing and not disclosed to the public” and called for increased surveillance of others with adverse effects, prompting China to launch a “zero COVID policy,” according to the report.
The Baoding municipal government’s foreign affairs workplace has issued policies stating that “people who test positive for IgM are quarantined at a centralized site” and released only after testing negative.
The Chinese government is conducting immediate testing because IgM appears to be in the early stages of COVID-19. However, IgM antibodies are positive after being vaccinated and quarantined for approximately 47 days. This is how China implemented its zero-COVID policy after its vaccines failed to deliver on their promises, according to Tibet Press.
In particular, China’s zero-COVID policy referred to strict measures, adding the imposition of lockdowns, mass testing and restrictions. China has begun to take steps to address this challenge by generating the world’s first “COVID inhalable vaccine” aimed at the elderly.
More than 60% of respondents in China’s Sichuan province said they had been tested for covid-19, NHK World reported, presenting a survey.
Authorities in Sichuan province conducted an online survey involving another 158,500 people and 63 percent said their PCR or antigen test results were positive. The province has a population of approximately 83 million.
Meanwhile, the Sichuan Center for Disease Control and Prevention said the actual percentage of other people likely became more inflamed, with only about 30 percent of those who did not undergo testing complaining of symptoms such as fever and cough, according to NHK World.
The increase comes after China relaxed its coronavirus containment measures on Dec. 7.
Follow:
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Advertising. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .